Jeffrey M Jacobson MD
Professor, Drexel University School of Medicine
Join to View Full Profile
3401 N Broad StPhiladelphia, PA 19140
Phone+1 215-707-3807
Fax+1 215-707-4414
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jeffrey Jacobson, MD is an infectious disease specialist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, Ohio, and New York. He is a Professor at Drexel University School of Medicine.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1978 - 1980
University of Wisconsin Hospitals and ClinicsInternship, Internal Medicine, 1977 - 1978
Weill Cornell MedicineClass of 1977
Certifications & Licensure
OH State Medical License 2019 - 2026
PA State Medical License 2006 - 2021
NY State Medical License 1978 - 2007
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 5 citationsLong-term safety of lentiviral or gammaretroviral gene-modified T cell therapies.Julie K Jadlowsky, Elizabeth O Hexner, Amy Marshall, Stephan A Grupp, Noelle V Frey
Nature Medicine. 2025-04-01 - Polygenic Risk Scores for CKD Among an Ethnically Diverse Cohort of People With HIV.Won Jun Lee, Deirdre Sawinski, Paul MacLennan, Haoxiang Cheng, Samreen Zafer
American Journal of Kidney Diseases. 2025-02-18 - Correction: Severity and Number of Substances Used are Independently Associated with Antiretroviral Therapy Adherence Over Time Among People with HIV in the Current Tr...Jimmy Ma, Joseph A C Delaney, Stephanie A Ruderman, Robin M Nance, Andrew W Hahn
AIDS and Behavior. 2025-02-01
Press Mentions
- University Hospitals and CWRU Join Global Study of AstraZeneca’s COVID-19 VaccineOctober 29th, 2020
